Dynamic Cell Therapies Overview
- Year Founded
-
2016
- Status
-
Out of Business
- Employees
-
16
- Latest Deal Type
-
Out of Business
Dynamic Cell Therapies General Information
Description
Developer of next-generation CAR (Chimeric Antigen Receptor) T-cell therapies designed for the treatment of liquid and solid tumors. The company develops transformative CAR T cell technology for multiplexing, titration, and modularity and treats relapsed or refractory cancers, enabling healthcare providers to focus on improving the safety, efficacy, durability, and accessibility of T-cell therapy by engineering life-saving constructs to alleviate patient suffering.
Contact Information
Website
www.dynamiccelltherapies.comCorporate Office
- 177 Arlington Street
- Medford, MA 02155
- United States
Corporate Office
- 177 Arlington Street
- Medford, MA 02155
- United States
Dynamic Cell Therapies Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Out of Business | 28-Apr-2026 | Completed | Out of Business | |||
| 3. Seed Round | 11-Jul-2024 | Completed | Generating Revenue | |||
| 2. Seed Round | 01-Nov-2022 | $2M | $5M | Completed | Pre-Clinical Trials | |
| 1. Seed Round | 26-Feb-2021 | $3M | $3M | Completed | Startup |
Dynamic Cell Therapies Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed-2 | ||||||||
| Seed |
Dynamic Cell Therapies Patents
Dynamic Cell Therapies Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025255266-A1 | Engineered polypeptides for immune cell activation | Pending | 05-Jun-2024 | ||
| WO-2025255266-A8 | Engineered polypeptides for immune cell activation | Pending | 05-Jun-2024 | ||
| WO-2025255267-A1 | Engineered receptors for activation of regulatory t-cells | Pending | 05-Jun-2024 | ||
| EP-4630446-A1 | Engineered switches for immune cell activity and methods of use thereof | Pending | 06-Dec-2022 | ||
| US-20250297022-A1 | Engineered switches for immune cell activity and methods of use thereof | Pending | 06-Dec-2022 | C07K16/2878 |
Dynamic Cell Therapies Signals
Dynamic Cell Therapies FAQs
-
When was Dynamic Cell Therapies founded?
Dynamic Cell Therapies was founded in 2016.
-
Where is Dynamic Cell Therapies headquartered?
Dynamic Cell Therapies is headquartered in Medford, MA.
-
What is the size of Dynamic Cell Therapies?
Dynamic Cell Therapies has 16 total employees.
-
What industry is Dynamic Cell Therapies in?
Dynamic Cell Therapies’s primary industry is Drug Discovery.
-
Is Dynamic Cell Therapies a private or public company?
Dynamic Cell Therapies is a Private company.
-
What is Dynamic Cell Therapies’s current revenue?
The current revenue for Dynamic Cell Therapies is .
-
How much funding has Dynamic Cell Therapies raised over time?
Dynamic Cell Therapies has raised $6M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process